Ted James, MD, MS, FACS
Vice Chair Academic Affairs, Chief of Breast Surgical Oncology, Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School
A member of the BIDMC/Harvard health system, Dr. Ted James manages the surgical care of breast cancer patients. He performs advanced breast surgical oncology procedures including oncoplastic and minimally invasive breast surgery. Dr. James also takes an active role promoting quality initiatives in cancer care delivery. He is active in research on improving outcomes in breast cancer surgery, including margin control during breast conserving surgery.
Dr. James employs a multidisciplinary, team-based approach to cancer care and believes that patients should be key members of the treatment decision-making process. He educates patients about their diagnosis and addresses their treatment priorities. He believes that care must also be compassionate and focus on the entire person including their physical, emotional and spiritual well-being.
In addition to his medical and surgical training, Dr. James obtained a Health Care Management degree from Harvard. Dr. James is also faculty at Harvard Medical School and serves in leadership roles with the Commission on Cancer and American Cancer Society. He is a fellow of the American College of Surgeons and member of the Society of Surgical Oncology and American Society of Breast Surgeons.
Frank Prendergast, MD
Former Director Emeritus, Mayo Clinic Comprehensive Cancer Center
Dr. Prendergast has held senior positions within Mayo Clinic: Chair, Department of Biochemistry & Molecular Biology; Director for Research, Mayo Clinic Rochester,'89-'92. Member of the Board of Governors for Mayo Clinic in Rochester; Mayo Clinic Board of Trustees,'92-'09; Mayo Clinic's Board of Governors, '99-'06. Mayo Distinguished Investigator, Emeritus Director of the Mayo Clinic Comprehensive Cancer Center and Emeritus Director of Mayo Center for Individualized Medicine.
Frank also served extensively for the National Institutes of Health, Board of Advisors for Division of Research Grants; National Advisory General Medical Sciences Council; Board of Scientific Advisors of National Cancer Institute; National Cancer Advisory Board.
He has received the following honors and awards: Rhodes Scholarship; DSc Purdue University and University West Indies, Outstanding Graduate from University West Indies; Outstanding Graduate College of Biological Sciences from University of Minnesota; Musgrave Gold Medal Institute of Jamaica.
Frank holds a medical degree with honors from University of West Indies; Oxford University Rhodes Scholar M.A. degree in physiology. After internal medicine residency at Mayo Clinic, he obtained the Ph.D. degree in biochemistry at University of Minnesota/Mayo Graduate School.
Brian Wilson, PhD
University of Toronto, Medical Biophysics Department, Princess Margaret Cancer Centre
Dr. Brian Wilson is internationally recognized for his pioneering research into various optic tools that can be used for minimally-invasive cancer treatment and early diagnosis. Dr. Wilson leads an internationally recognized R&D program in optics-based biomedical applications, with a primary translational / clinical focus. Dr. Wilson has published over 300 peer-reviewed papers in basic, translational and clinical research, and has trained more than 60 graduate students and postdoctoral and clinical fellows. He holds, or has held, several international Visiting Appointments (Harvard, USA; Saõ Paulo, Brazil; Fujian, China; Western Australia) and is involved in many national and international collaborations. He is currently head of the division of biophysics and bio-imaging at the Ontario Cancer Institute and professor of medical biophysics in the faculty of medicine at University of Toronto.